Geron Corporation (GERN)

Geron Corporation (GERN) is a healthcare company (biotechnology) based in the United States. The share price is $0.98, up 4.07% on the day, which values the company at $631.48M. Price as of 17 Nov 2026, 17:29 UTC, from Yahoo Finance.

Key facts

Share price
$0.98+4.07% today
Market value
$631.48M
Forward P/E
10.9×
Funk Score
48/100
Against its own history
Well below its usual priceusual price $22.90
200-week average
$2.3458% below
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Geron Corporation in more detail

GERN trades at 10.9× next year's expected earnings, 2.9× sales. Measured against its own history, the price is 96% below what its usual multiples would imply ($22.90) — well below its usual price. It sits 58% below its 200-week average of $2.34.

Over the last five fiscal years Geron Corporation has compounded revenue 273.5% a year. Its Funk Score is 48 out of 100 (financial strength 3.1, profitability 2.5, growth 8.7, value 5.0, each out of 10).

In its favour: More cash than debt. Worth checking: Altman Z in the distress zone; Beneish M-score flags the accounts.

2 of the superinvestors tracked here hold GERN, including Peter Kolchinsky (0.5% of the portfolio), Andrew Spokes (0.0% of the portfolio).

Superinvestors holding GERN

2 of the investors tracked here report a position in their latest 13F filing.

Geron Corporation (GERN): questions and answers

What is Geron Corporation's market cap?

Geron Corporation is valued at $631.48M at a share price of $0.98.

Is GERN overvalued or undervalued?

Against its own history, GERN is well below its usual price: the price is 96% below the $22.90 implied by the median multiples it has traded at (price / sales, price / book). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.

Is GERN above its 200-week moving average?

No. GERN is 58.1% below its 200-week average of $2.34. Long-term investors watch that line because strong companies rarely trade below it for long.

How fast is Geron Corporation growing?

Over the last five fiscal years Geron Corporation's revenue grew 273.5% a year; over ten years revenue grew 17.6% a year.

Does GERN pay a dividend?

Geron Corporation does not currently pay a regular dividend.

Which famous investors own GERN?

In their latest quarterly filings, Peter Kolchinsky (0.5% of the portfolio), Andrew Spokes (0.0% of the portfolio) hold GERN. These filings are published up to 45 days after each quarter ends, so positions may have changed since.

Cite this page

Funkfolio, “Geron Corporation (GERN) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/GERN

Underlying data: Yahoo Finance; company filings with the SEC.